Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses And Other Current Liabilities (Details)

v3.20.2
Accrued Expenses And Other Current Liabilities (Details) - USD ($)
Apr. 24, 2020
Sep. 30, 2020
Dec. 31, 2019
Accrued Liabilities and Other Liabilities [Abstract]      
Research and development expenses   $ 3,381,457 $ 920,901
Compensation and benefits   2,431,358 1,591,964
General and administrative   705,867 360,016
Sales and marketing   142,000 120,056
Sales returns and allowances   1,520,716 2,284,175
Medicaid rebates   93,701 118,271
Lease liability, current   448,659 155,815
Other   86,964 89,054
Total accrued expenses and other current liabilities   8,810,722 $ 5,640,252
Written notice, term 30 days    
Accrued severance $ 800,000 $ 800,000  
Accrued severance costs, term 18 months